InsiderTrades.com logo
William Robert Elder net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

William Elder Biography and Net Worth

Chief Financial Officer and General Counsel of CervoMed

William (Bill) Elder serves as General Counsel and Corporate Secretary at CervoMed, joining the company in August 2023. He is an attorney with nearly a decade of experience advising public and private companies in a variety of corporate, securities, governance, regulatory, and general commercial matters.

Prior to joining CervoMed, Bill served as Diffusion Pharmaceutical’s General Counsel from September 2020 to August 2023 and as its Principal Financial Officer from June 2023 to August 2023, after starting as a consultant for Diffusion in July 2020. Previously, Bill spent eight years as an associate at the law firm of Dechert LLP, counseling clients in a broad range of transactions and other matters, including serving as outside counsel to Diffusion in connection with the Company’s reverse merger in 2016 and several subsequent financings.

Bill received a JD from the University of Pennsylvania School in Law, an MSF from Villanova University, and a BA in Economics from Tufts University.

What is William Robert Elder's net worth?

The estimated net worth of William Robert Elder is at least $25.85 thousand as of November 17th, 2025. Mr. Elder owns 10,000 shares of CervoMed stock worth more than $25,850 as of September 25th. This net worth approximation does not reflect any other assets that Mr. Elder may own. Learn More about William Robert Elder's net worth.

How do I contact William Robert Elder?

The corporate mailing address for Mr. Elder and other CervoMed executives is 20 Park Plaza, Suite 424, Boston, MA, 02116. CervoMed can also be reached via phone at (617) 744-4400 and via email at [email protected]. Learn More on William Robert Elder's contact information.

Has William Robert Elder been buying or selling shares of CervoMed?

William Robert Elder has not been actively trading shares of CervoMed within the last three months. Most recently, on Tuesday, November 18th, William Robert Elder bought 2,500 shares of CervoMed stock. The stock was acquired at an average cost of $8.32 per share, with a total value of $20,800.00. Following the completion of the transaction, the chief financial officer now directly owns 12,500 shares of the company's stock, valued at $104,000. Learn More on William Robert Elder's trading history.

Who are CervoMed's active insiders?

CervoMed's insider roster includes William Elder (Chief Financial Officer and General Counsel), and Matthew Winton (Chief Commercial and Business Officer). Learn More on CervoMed's active insiders.

Are insiders buying or selling shares of CervoMed?

In the last year, CervoMed insiders bought shares 19 times. They purchased a total of 1,047,414 shares worth more than $3,737,723.28. The most recent insider tranaction occured on June, 11th when Director Joshua S Boger bought 955,414 shares worth more than $2,999,999.96. Insiders at CervoMed own 35.8% of the company. Learn More about insider trades at CervoMed.

Information on this page was last updated on 6/11/2026.

William Robert Elder Insider Trading History at CervoMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/18/2025Buy2,500$8.32$20,800.0012,500View SEC Filing Icon  
11/17/2025Buy1,000$8.45$8,450.0010,000View SEC Filing Icon  
11/12/2025Buy3,500$7.44$26,040.009,000View SEC Filing Icon  
See Full Table

William Robert Elder Buying and Selling Activity at CervoMed

This chart shows William Robert Elder's buying and selling at CervoMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CervoMed Company Overview

CervoMed logo
CervoMed Inc., a biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. Its lead drug candidate is neflamapimod, an orally administered small molecule brain penetrant for the treatment of dementia with Lewy bodies (DLB), Alzheimer's diseases, frontotemporal dementia, and ischemic stroke recovery. The company also develops EIP200 for central nervous system which is in preclinical trials. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Read More

Today's Range

Now: $2.55
Low: $2.52
High: $2.63

50 Day Range

MA: $2.65
Low: $2.41
High: $3.09

2 Week Range

Now: $2.55
Low: $2.13
High: $10.00

Volume

66,068 shs

Average Volume

1,984,973 shs

Market Capitalization

$38.48 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A